EU member states do not support "information to patients" strand of pharma package
This article was originally published in Scrip
Executive Summary
22 member states of the EU are not in favour of the "information to patients" strand of the European Commission's proposed package of new pharma legislation, and it is likely that it will not go ahead, industry officials revealed at the annual meeting of the European pharmaceutical industry association, EFPIA, in Seville, Spain, this week.